Inventory, Net of VERTEX PHARMACEUTICALS INC / MA from 31 Mar 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Inventory, Net in USD history and change rate from 31 Mar 2011 to 31 Dec 2025.
  • VERTEX PHARMACEUTICALS INC / MA Inventory, Net for the quarter ending 31 Dec 2025 was $1,686,800,000, a 40% increase year-over-year.
Source SEC data
View on sec.gov
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Inventory, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,686,800,000 +$481,400,000 +40% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 $1,626,800,000 +$547,000,000 +51% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $1,499,300,000 +$584,700,000 +64% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $1,359,700,000 +$546,600,000 +67% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $1,205,400,000 +$466,600,000 +63% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q3 2024 $1,079,800,000 +$391,100,000 +57% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $914,600,000 +$311,100,000 +52% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $813,100,000 +$278,000,000 +52% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $738,800,000 +$278,200,000 +60% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 $688,700,000 +$300,500,000 +77% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $603,500,000 +$235,800,000 +64% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $535,100,000 +$196,200,000 +58% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $460,600,000 +$107,500,000 +30% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 $388,200,000 +$54,744,000 +16% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $367,700,000 +$46,080,000 +14% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $338,900,000 +$40,037,000 +13% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $353,100,000 +$72,300,000 +26% 31 Dec 2021 10-K 10 Feb 2023 2022 FY
Q3 2021 $333,456,000 +$87,996,000 +36% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $321,620,000 +$102,402,000 +47% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $298,863,000 +$111,776,000 +60% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $280,800,000 +$113,298,000 +68% 31 Dec 2020 10-K 09 Feb 2022 2021 FY
Q3 2020 $245,460,000 +$83,154,000 +51% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $219,218,000 +$76,201,000 +53% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $187,087,000 +$50,389,000 +37% 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 $167,502,000 +$43,142,000 +35% 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q3 2019 $162,306,000 +$38,156,000 +31% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $143,017,000 +$27,992,000 +24% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $136,698,000 +$19,352,000 +16% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $124,360,000 +$12,530,000 +11% 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q3 2018 $124,150,000 +$25,958,000 +26% 30 Sep 2018 10-Q 25 Oct 2018 2018 Q3
Q2 2018 $115,025,000 +$22,762,000 +25% 30 Jun 2018 10-Q 26 Jul 2018 2018 Q2
Q1 2018 $117,346,000 +$35,326,000 +43% 31 Mar 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 $111,830,000 +$34,226,000 +44% 31 Dec 2017 10-K 13 Feb 2019 2018 FY
Q3 2017 $98,192,000 +$26,393,000 +37% 30 Sep 2017 10-Q 30 Oct 2017 2017 Q3
Q2 2017 $92,263,000 +$25,674,000 +39% 30 Jun 2017 10-Q 28 Jul 2017 2017 Q2
Q1 2017 $82,020,000 +$18,820,000 +30% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 $77,604,000 +$20,397,000 +36% 31 Dec 2016 10-K 15 Feb 2018 2017 FY
Q3 2016 $71,799,000 +$22,602,000 +46% 30 Sep 2016 10-Q 31 Oct 2016 2016 Q3
Q2 2016 $66,589,000 +$24,476,000 +58% 30 Jun 2016 10-Q 01 Aug 2016 2016 Q2
Q1 2016 $63,200,000 +$29,111,000 +85% 31 Mar 2016 10-Q 03 May 2016 2016 Q1
Q4 2015 $57,207,000 +$26,359,000 +85% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q3 2015 $49,197,000 +$32,444,000 +194% 30 Sep 2015 10-Q 30 Oct 2015 2015 Q3
Q2 2015 $42,113,000 +$30,131,000 +251% 30 Jun 2015 10-Q 04 Aug 2015 2015 Q2
Q1 2015 $34,089,000 +$22,828,000 +203% 31 Mar 2015 10-Q 04 May 2015 2015 Q1
Q4 2014 $30,848,000 +$16,701,000 +118% 31 Dec 2014 10-K 16 Feb 2016 2015 FY
Q3 2014 $16,753,000 +$3,216,000 +24% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 $11,982,000 -$7,527,000 -39% 30 Jun 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 $11,261,000 -$10,271,000 -48% 31 Mar 2014 10-Q 05 May 2014 2014 Q1
Q4 2013 $14,147,000 -$16,317,000 -54% 31 Dec 2013 10-K 13 Feb 2015 2014 FY
Q3 2013 $13,537,000 -$72,738,000 -84% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $19,509,000 -$68,296,000 -78% 30 Jun 2013 10-Q 02 Aug 2013 2013 Q2
Q1 2013 $21,532,000 -$108,063,000 -83% 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 $30,464,000 -$81,966,000 -73% 31 Dec 2012 10-K 11 Feb 2014 2013 FY
Q3 2012 $86,275,000 +$18,621,000 +28% 30 Sep 2012 10-Q 06 Nov 2012 2012 Q3
Q2 2012 $87,805,000 +$35,183,000 +67% 30 Jun 2012 10-Q 08 Aug 2012 2012 Q2
Q1 2012 $129,595,000 +$111,779,000 +627% 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 $112,430,000 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 $67,654,000 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 $52,622,000 30 Jun 2011 10-Q 09 Aug 2011 2011 Q2
Q1 2011 $17,816,000 31 Mar 2011 10-Q 06 May 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.